Alaunos Therapeutics reported $2.21M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Amgen USD 538M 300K Sep/2025
AstraZeneca USD 1.55B 1.16B Sep/2025
Baxter International USD 683M 0 Dec/2024
Biogen USD 146.7M 200K Sep/2025
Bioline Rx USD 62.57M 24.47M Mar/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Celltrion KRW 218.78M 1.5M Sep/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
Cspc Pharmaceutical CNY 11.52B 486M Jun/2025
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Divis Laboratories Ltd INR 265.47M 264.53M Sep/2025
Gilead Sciences USD 1.24B 0 Sep/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
Incyte USD 196.13M 2.01M Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
J&J USD 2.41B 584K Sep/2025
Kangmei Pharma CNY 13.86B 0 Jun/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 115.01M 9.28M Dec/2024
Merck USD 2.49B 15.79M Sep/2025
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Novartis USD 1.94B 23.4M Jun/2025
Organigram Holdings CAD 134.46M 438.86K Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Pharma Mar EUR 17.58M 0 Sep/2025
PTC Therapeutics USD 79.93M 554K Sep/2025
Qiagen NV USD 216.84M 7K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sartorius EUR 69.04M 0 Sep/2025
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
Tilray USD 1.06B 86.93M Mar/2025
Zz Pientze Pharmaceu CNY 603.32M 0 Sep/2025